Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma
- PMID: 1260756
Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma
Abstract
A methylcholanthrene-induced fibrosarcoma of C3H mice has been used as 5th- to 6th-generation syngeneic transplant in an investigation of the role of Corynebacterium parvum as an adjuvant to the therapeutic effect of local irradiation of established tumors. The most effective route for administration of C. parvum in this tumor system was i.v., and the greatest effect of the C. parvum-mediated tumor graft rejection was observed for tumor growing intracutaneously or s.c. An intermediate level of effectiveness was obtained for tumor growing i.m. The combined C. parvum and local irradiation studies were performed using tumors growing in the leg muscle and measuring 8 mm in diameter at the time of local irradiation. Several routes of administration of C. parvum, dose levels of C. parvum, and time relationships between administration of C. parvum and irradiation were investigated. The outstanding finding was that very low doses of radiation were quite effective when administered to tumors growing in animals pretreated with C. parvum. This was true for radiation administered as a single or fractionated dose (10 equal doses spread over 18 days). For single-dose irradiation the effect was relatively dose independent over the range of 200 to 3000 rads. Some indication was obtained that local irradiation may impair the tumor graft rejection reaction. No evidence was obtained of an enhanced growth of tumor. Regression of tumor following irradiation was not modified by pretreatment with C. parvum. The mice that were unsuccessfully treated by radiation and C. parvum had a lower incidence of metastatic disease in the lung than did the mice treated unsuccessfully with radiation alone.
Similar articles
-
Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma.Radiology. 1977 Oct;125(1):235-41. doi: 10.1148/125.1.235. Radiology. 1977. PMID: 897175
-
Treatment of rat fibrosarcoma by radiotherapy plus immune adjuvant.Biomedicine. 1976 May;25(3):97-100. Biomedicine. 1976. PMID: 949523
-
Radiation therapy and Corynebacterium parvum in the treatment of murine tumors.Cancer. 1976 Jun;37(6):2573-9. doi: 10.1002/1097-0142(197606)37:6<2573::aid-cncr2820370602>3.0.co;2-c. Cancer. 1976. PMID: 949676
-
Tumor inhibitory properties of anaerobic Corynebacteria.Transplant Proc. 1975 Jun;7(2):229-32. Transplant Proc. 1975. PMID: 1093294 Review. No abstract available.
-
Radiation enhancement of metastasis: a review.Clin Exp Metastasis. 1991 Mar-Apr;9(2):77-104. doi: 10.1007/BF01756381. Clin Exp Metastasis. 1991. PMID: 2032423 Review.
Cited by
-
Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model.J Neurooncol. 1993 Feb;15(2):113-23. doi: 10.1007/BF01053932. J Neurooncol. 1993. PMID: 8509816
-
Neuroimmune mechanisms of behavioral alterations in a syngeneic murine model of human papilloma virus-related head and neck cancer.Psychoneuroendocrinology. 2017 May;79:59-66. doi: 10.1016/j.psyneuen.2017.02.006. Epub 2017 Feb 11. Psychoneuroendocrinology. 2017. PMID: 28259044 Free PMC article.
-
Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma.Cancer Chemother Pharmacol. 1982;9(3):148-55. doi: 10.1007/BF00257743. Cancer Chemother Pharmacol. 1982. PMID: 6961973
-
Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression.Behav Brain Res. 2016 Jan 15;297:241-50. doi: 10.1016/j.bbr.2015.10.024. Epub 2015 Oct 22. Behav Brain Res. 2016. PMID: 26475509 Free PMC article.
-
A Century of Radiation Therapy and Adaptive Immunity.Front Immunol. 2017 Apr 11;8:431. doi: 10.3389/fimmu.2017.00431. eCollection 2017. Front Immunol. 2017. PMID: 28443099 Free PMC article. Review.